Design of a Novel Integration-deficient Lentivector Technology That Incorporates Genetic and Posttranslational Elements to Target Human Dendritic Cells-Reference-Cited by-同舟云学术

Design of a Novel Integration-deficient Lentivector Technology That Incorporates Genetic and Posttranslational Elements to Target Human Dendritic Cells

Published:2014-03 Issue:3 Volume:22 Page:575-587
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Tareen Semih U,Kelley-Clarke Brenna,Nicolai Christopher J,Cassiano Linda A,Nelson Lisa T,Slough Megan M,Vin Chintan D,Odegard Jared M,Sloan Derek D,Van Hoeven Neal,Allen James M,Dubensky Thomas W,Robbins Scott H

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference67 articles.

1. Cancer immunotherapy comes of age;Mellman;Nature,2011

2. Dendritic cells: specialized and regulated antigen processing machines;Mellman;Cell,2001

3. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells;Hsu;Nat Med,1996

4. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination;Bonifaz;J Exp Med,2004

5. DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses;Klimstra;J Virol,2003

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intratumoral expression of IL-12 from lentiviral or RNA vectors acts synergistically with TLR4 agonist (GLA) to generate anti-tumor immunological memory;PLOS ONE;2021-12-02

2. An Update on the HIV DNA Vaccine Strategy;Vaccines;2021-06-05

3. The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology;Viruses;2020-09-29

4. Intratumoral immune activation with TLR4 agonist synergizes with effector T cells to eradicate established murine tumors;npj Vaccines;2020-06-16

5. Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine;Vaccine;2020-04